PMID- 24375792 OWN - NLM STAT- MEDLINE DCOM- 20140328 LR - 20211021 IS - 1522-1504 (Electronic) IS - 1040-0605 (Print) IS - 1040-0605 (Linking) VI - 306 IP - 3 DP - 2014 Feb TI - Peroxisome proliferator activated receptor-gamma-Rho-kinase interactions contribute to vascular remodeling after chronic intrauterine pulmonary hypertension. PG - L299-308 LID - 10.1152/ajplung.00271.2013 [doi] AB - Peroxisome proliferator-activated receptor-gamma (PPARgamma) and Rho-kinase (ROCK) regulate smooth muscle cell (SMC) proliferation and contribute to vascular remodeling in adult pulmonary hypertension. Whether these pathways interact to contribute to the development of vascular remodeling in persistent pulmonary hypertension of the newborn (PPHN) remains unknown. We hypothesized that ROCK-PPARgamma interactions increase SMC proliferation resulting in vascular remodeling in experimental PPHN. Pulmonary artery SMCs (PASMCs) were harvested from fetal sheep after partial ligation of the ductus arteriosus in utero (PPHN) and controls. Cell counts were performed daily for 5 days with or without PPARgamma agonists and ROCK inhibition. PPARgamma and ROCK protein expression/activity were measured by Western blot in normal and PPHN PASMCs. We assessed PPARgamma-ROCK interactions by studying the effect of ROCK activation on PPARgamma activity and PPARgamma inhibition (siRNA) on ROCK activity and PASMC proliferation. At baseline, PPHN PASMC cell number was increased by 38% above controls on day 5. ROCK protein expression/activity were increased by 25 and 34% and PPARgamma protein/activity decreased by 40 and 50% in PPHN PASMC. ROCK inhibition and PPARgamma activation restored PPHN PASMC growth to normal values. ROCK inhibition increased PPARgamma activity by 50% in PPHN PASMC, restoring PPARgamma activity to normal. In normal PASMCs, ROCK activation decreased PPARgamma activity and PPARgamma inhibition increased ROCK activity and cell proliferation, resulting in a PPHN hyperproliferative PASMC phenotype. PPARgamma-ROCK interactions regulate SMC proliferation and contribute to increased PPHN PASMC proliferation and vascular remodeling in PPHN. Restoring normal PPARgamma-ROCK signaling may prevent vascular remodeling and improve outcomes in PPHN. FAU - Gien, Jason AU - Gien J AD - Perinatal Research Facility, 13243 E. 23rd Ave., Mail Stop F441, Aurora, CO 80045. jason.gien@ucdenver.edu. FAU - Tseng, Nancy AU - Tseng N FAU - Seedorf, Gregory AU - Seedorf G FAU - Roe, Gates AU - Roe G FAU - Abman, Steven H AU - Abman SH LA - eng GR - K08 HL102261/HL/NHLBI NIH HHS/United States GR - R01 HL068702/HL/NHLBI NIH HHS/United States GR - R01 HL068702-05A2/HL/NHLBI NIH HHS/United States GR - 5K08HL102261/HL/NHLBI NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20131227 PL - United States TA - Am J Physiol Lung Cell Mol Physiol JT - American journal of physiology. Lung cellular and molecular physiology JID - 100901229 RN - 0 (PPAR gamma) RN - EC 2.7.11.1 (rho-Associated Kinases) SB - IM MH - Animals MH - PPAR gamma/antagonists & inhibitors/biosynthesis/*metabolism MH - Persistent Fetal Circulation Syndrome/*metabolism MH - Sheep MH - Signal Transduction MH - rho-Associated Kinases/biosynthesis/*metabolism PMC - PMC3920199 OTO - NOTNLM OT - Rho-kinase (ROCK) OT - peroxisome proliferator-activated gamma (PPARgamma) OT - persistent pulmonary hypertension of the newborn (PPHN) OT - pulmonary artery smooth muscle cells (PASMC) OT - vascular remodeling EDAT- 2014/01/01 06:00 MHDA- 2014/03/29 06:00 PMCR- 2015/02/01 CRDT- 2013/12/31 06:00 PHST- 2013/12/31 06:00 [entrez] PHST- 2014/01/01 06:00 [pubmed] PHST- 2014/03/29 06:00 [medline] PHST- 2015/02/01 00:00 [pmc-release] AID - ajplung.00271.2013 [pii] AID - L-00271-2013 [pii] AID - 10.1152/ajplung.00271.2013 [doi] PST - ppublish SO - Am J Physiol Lung Cell Mol Physiol. 2014 Feb;306(3):L299-308. doi: 10.1152/ajplung.00271.2013. Epub 2013 Dec 27.